Thursday, July 24, 2014 2:04:21 PM
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
NELSON GRIST <nelson@atyg.net>
1:35 PM (26 minutes ago)
to me
Robert,
As of right now there has been know decsion one way or another in regards to ATYG. I can’t speak for the other management team regarding a buy back. I am working on getting it current on OTC MARKETS and once that has been accomplished, I will put the company on the right path towards success for ATYG.
Thank you,
Nelson Grist
Cell 602 502-0602
Fax 480 302-8444
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
-IMHO
Recent ATYG News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:00:08 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/13/2023 03:40:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/04/2023 02:42:16 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM